Ginsenoside Rk3 alleviated DSS-induced ulcerative colitis by protecting colon barrier and inhibiting NLRP3 inflammasome pathway

M Tian, P Ma, Y Zhang, Y Mi, D Fan - International Immunopharmacology, 2020 - Elsevier
Ginsenosides have a variety of pharmacological activities, including immunomodulatory,
antitumor and anti-inflammatory activities. However, the effect of Rk3 on ulcerative colitis has …
被引用次数：56 相关文章

Ginsenoside Rk3 alleviated DSS-induced ulcerative colitis by protecting colon barrier and inhibiting NLRP3 inflammasome pathway

M Tian, P Ma, Y Zhang, Y Mi… - International …, 2020 - pubmed.ncbi.nlm.nih.gov
Ginsenosides have a variety of pharmacological activities, including immunomodulatory,
antitumor and anti-inflammatory activities. However, the effect of Rk3 on ulcerative colitis has …

Ginsenoside Rk3 alleviated DSS-induced ulcerative colitis by protecting colon barrier and inhibiting NLRP3 inflammasome pathway.

M Tian, P Ma, Y Zhang, Y Mi, D Fan - International …, 2020 - europepmc.org
Ginsenosides have a variety of pharmacological activities, including immunomodulatory,
antitumor and anti-inflammatory activities. However, the effect of Rk3 on ulcerative colitis has …

Ginsenoside Rk3 alleviated DSS-induced ulcerative colitis by protecting colon barrier and inhibiting NLRP3 inflammasome pathway.

M Tian, Y Zhang, Y Mi, D Fan - 2020 - cabidigitallibrary.org
Ginsenosides have a variety of pharmacological activities, including immunomodulatory,
antitumor and anti-inflammatory activities. However, the effect of Rk3 on ulcerative colitis has …